Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v6-EN Version v3-EN
Language English English
Date Updated 2023-03-18 2023-02-04
Drug Identification Number 02219336 02219336
Brand name DIPHENIST 50MG/ML DIPHENIST 50MG/ML
Common or Proper name Diphenhydramine Hydrochloride Injection USP Diphenhydramine Hydrochloride Injection USP
Company Name OMEGA LABORATORIES LIMITED OMEGA LABORATORIES LIMITED
Ingredients DIPHENHYDRAMINE HYDROCHLORIDE DIPHENHYDRAMINE HYDROCHLORIDE
Strength(s) 50MG 50MG
Dosage form(s) LIQUID LIQUID
Route of administration INTRAVENOUS INTRAMUSCULAR INTRAVENOUS INTRAMUSCULAR INTRAVENOUS INTRAMUSCULAR INTRAVENOUS INTRAMUSCULAR
Packaging size 10 x 1 mL vial / fiole 10 x 1 mL vial / fiole
ATC code R06AA R06AA
ATC description ANTIHISTAMINES FOR SYSTEMIC USE ANTIHISTAMINES FOR SYSTEMIC USE
Reason for shortage Demand increase for the drug. Demand increase for the drug.
Anticipated start date
Actual start date 2023-02-03 2023-02-03
Estimated end date 2023-03-21 2023-03-21
Actual end date 2023-03-17
Shortage status Resolved Actual shortage
Tier 3 Status No No
Company comments Stock available at CPDN Calgary
Health Canada comments